Methyluracil (Methyluracil)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceDioxomethyltetrahydropyrimidineDioxomethyltetrahydropyrimidine
Similar drugsTo uncover
  • Methyluracil
    ointment locally externally 
    TULA PHARMACEUTICAL FACTORY, LTD.     Russia
  • Methyluracil
    ointment locally externally 
    St. Petersburg Research Institute of Vaccines and Serums and the enterprise for the production of bacterial preparations FSUE FMBA    
  • Methyluracil
    suppositories rect. 
    Promomed Rus, Open Company     Russia
  • Methyluracil
    pills inwards 
    UPDATE OF PFC, CJSC     Russia
  • Methyluracil
    ointment externally 
    GREEN DUBRAVA, CJSC     Russia
  • Methyluracil
    ointment locally externally 
    MUROMSKY INSTRUMENT-MAKING PLANT, OJSC     Russia
  • Methyluracil
    ointment locally externally 
    Promomed Rus, Open Company     Russia
  • Methyluracil
    suppositories rect. 
    ALTAYVITAMINS, CJSC     Russia
  • Methyluracil
    suppositories rect. 
    YUZHFARM, LLC     Russia
  • Methyluracil-ACOS
    ointment externally 
    SYNTHESIS, OJSC     Russia
  • Metouracol
    sponge externally 
    BELKOZIN - LUZHSKY FACTORY, OJSC     Russia
  • Oxolin
    ointment externally 
    TULA PHARMACEUTICAL FACTORY, LTD.     Russia
  • Stisamet®
    ointment locally externally 
    RETYNOIDS FNPP, CJSC     Russia
    • Dosage form: & nbspointment for topical and topical application
    Composition:

    Active substance: methyluracil - 10.0 g.

    Excipients: Vaseline - 45.0 g; lanolin anhydrous - 31.5 g; purified water - 13.5 g.
    Description:Ointment from light yellow to yellow.
    Pharmacotherapeutic group:Reparation of tissue stimulant
    ATX: & nbsp

    D.11.A.X   Other preparations for the treatment of skin diseases

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:Has anabolic activity. Normalizing the nucleic acid metabolism, accelerates the processes of cellular regeneration in wounds, accelerates the growth and granulation maturation of the tissue and epithelization. With external application has photoprotective properties.
    Indications:

    Sluggish wounds, burns, photodermatitis.

    Prevention of skin reactions when irradiating neoplasms with low radiosensitivity, reducing the symptoms of radiation dermatitis and late fusion of the walls (occlusions) of the vagina - in the case of radiation therapy for neoplasms of the genitals.
    Contraindications:Hypersensitivity to the components of the drug, redundancy of granulations.
    Carefully:Pregnancy, the period of breastfeeding, children under 12 years.
    Pregnancy and lactation:The use of the drug is possible only if the intended benefit to the mother exceeds the potential risk to the fetus and the baby. If it is necessary to prescribe the drug during lactation, breastfeeding should be discontinued.
    Dosing and Administration:

    Outwardly. Locally.

    Ointment is applied daily to the affected areas with a thin layer of 5-10 g daily for 15-30 days. Before the application, the wound should be treated with an antiseptic and the remains of necrotic tissue removed.

    In the case of radiotherapy of neoplasms of the genitals for the prevention and treatment of radio-epithelium, ointment is used in loose tampons. The course of treatment is individual.
    Side effects:Allergic reactions, short-term burning in the place of application of the drug.
    Overdose:Cases of overdose with topical and topical application are not described.
    Interaction:The drug is compatible with external applications of antibacterial and antiseptic agents.
    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the performance of potentially hazardous activities requiring special attention and quick reactions (dispatcher work, vehicle management, work with moving mechanisms).

    Form release / dosage:

    Ointment for topical and topical application 10%.

    Packaging:

    By 25 grams, 30 grams in cans of polyethylene with polymeric lids.

    By 25 g, 30 g in cans of polyethylene terephthalate with polymer lids.

    To 25 g in cans of orange glass with a triangular aureole with polymeric lids.

    For 25 grams, 30 grams of aluminum tubes.

    Each jar or tube together with the instruction for use is placed in a pack of cardboard.

    For hospitals: 30 or 60 cans, together with an equal number of instructions for use, are placed in boxes of corrugated cardboard; 40 or 99 tubes together with an equal number of instructions for use are placed in boxes of corrugated cardboard.

    Storage conditions:

    At a temperature not exceeding 20 ° C.

    Keep out of the reach of children.

    Shelf life:

    3 years 6 months.

    Do not use after the expiration date printed on the package.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002576
    Date of registration:13.08.2014
    Expiration Date:13.08.2019
    The owner of the registration certificate:TULA PHARMACEUTICAL FACTORY, LTD. TULA PHARMACEUTICAL FACTORY, LTD. Russia
    Manufacturer: & nbsp
    Information update date: & nbsp07.05.2018
    Illustrated instructions
      Instructions
      Up